الصفحة الرئيسية>>Signaling Pathways>> Angiogenesis>> Antiangiogenics>>OGT 2115

OGT 2115

رقم الكتالوجGC15199

OGT 2115 هو مثبط هيباراناز قوي ، منفذ للخلايا ونشط عن طريق الفم مع IC 50 من 0.4 ميكرومترOGT 2115 له خصائص مضادة لتولد الأوعية (IC50 من 1 ميكرومتر)يمنع OGT 2115 أيضًا نشاط تحلل كبريتات الهيباران

Products are for research use only. Not for human use. We do not sell to patients.

OGT 2115 التركيب الكيميائي

Cas No.: 853929-59-6

الحجم السعر المخزون الكميّة
5mg
72٫00
Ship Within 7 Days
10mg
126٫00
Ship Within 7 Days
25mg
270٫00
Ship Within 7 Days
50mg
450٫00
Ship Within 7 Days
100mg
720٫00
Ship Within 7 Days

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties of OGT 2115

Cas No. 853929-59-6 SDF
Chemical Name (Z)-2-(2-(4-((1-(4-bromophenyl)-3-oxoprop-1-en-2-yl)amino)-3-fluorophenyl)benzo[d]oxazol-5-yl)acetic acid
Canonical SMILES BrC1=CC=C(C=C1)/C=C(C=O)\NC2=CC=C(C=C2F)C3=NC4=CC(CC(O)=O)=CC=C4O3
Formula C24H16BrFN2O4 M.Wt 495.3
الذوبان <4.95mg/ml in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of OGT 2115

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.019 mL 10.0949 mL 20.1898 mL
5 mM 0.4038 mL 2.019 mL 4.038 mL
10 mM 0.2019 mL 1.0095 mL 2.019 mL
  • حاسبة المولارية

  • حاسبة التخفيف

  • Molecular Weight Calculator

كتلة
=
تركيز
x
مقدار
x
ميغاواط *
 
 
 
** عند إعداد حلول المخزون، دائمًا استخدم الوزن الجزيئي الخاص بالدفعة للمنتج على ملصق القارورة MSDS / CoA (متوفر عبر الإنترنت).

احسب

In vivo Formulation Calculator (Clear solution) of OGT 2115

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

مراجعات

Review for OGT 2115

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for OGT 2115

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.